Aristotle Atlantic Partners, LLC, an investment advisor, released its “Focus Growth Strategy” third quarter 2024 investor ...

Thermo Fisher Scientific Inc.'s Q3 results demonstrated some end-market stability, particularly in the life science market.

We came across a bullish thesis on Thermo Fisher Scientific Inc. (TMO) on Kontra Investment Xchange’s Substack by Kontra. In ...

Contract drug manufacturers witnessed reduced spending from biotech clients last year, but recent interest cuts could improve ...

Thermo Fisher Scientific, which has a laboratory in Center Valley and an Allentown location, made special note of the new ...

Thermo Fisher Scientific has joined forces with Labguru to integrate Labguru’s Electronic Lab Notebook (ELN) into Thermo Fisher’s Laboratory Information Management System (LIMS) and lab operations ...

Thermo Fisher Scientific's third-quarter profit declined and revenue missed estimates as its two biggest divisions struggled.

RBC Capital lowered the firm’s price target on Thermo Fisher (TMO) to $718 from $767 but keeps an Outperform rating on the shares. The ...

Thermo FisherScientific has announced the signing of a Memorandum of Understanding (MoU) with the Government of Telangana to ...

The fetal abnormality test measures the most common chromosomal abnormalities, including Down syndrome, via a single-tube PCR process.

Q3 2024 Earnings Call Transcript October 23, 2024 Thermo Fisher Scientific Inc. beats earnings expectations. Reported EPS is ...

For the full year 2024, Thermo Fisher raised the lower end of its adjusted EPS guidance to a new range of $21.35 to $22.07, ...